miR ‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition-Reference-Cited by-同舟云学术

miR ‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition

Published:2021-03 Issue:12 Volume:148 Page:3071-3085
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Xiang Pu¹,Yeung Yiu To²,Wang Jiheng³,Wu Qiong²⁴,Du Ruijuan²⁴,Huang Chuntian²⁴,Jia Xuechao²⁴,Gao Yunfeng²,Zhi Yafei²⁴,Guo Fangqin⁴,Wei Huifang²⁴,Zhang Dandan²,Liu Yuzhang¹,Liu Lina¹,Liang Lijie¹,Wang Juan¹,Song Yongping¹,Liu Kangdong²⁴⁵^ORCID,Fang Baijun¹^ORCID

Affiliation:

1. Department of Hematology Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Hematology Institute Zhengzhou Henan China

2. China‐US (Henan) Hormel Cancer Institute Zhengzhou Henan China

3. Department of Head and Neck Thyroid Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou Henan China

4. Department of Pathophysiology, School of Basic Medical Sciences Zhengzhou University Zhengzhou Henan China

5. Cancer Chemoprevention International Collaboration Laboratory Zhengzhou Henan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33528